Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor

American Journal of Gastroenterology

Volumn 94, Issue 10, 1999, Pages 2885-2889

  Coyle, Walter J ^a   Sedlack, Robert E ^a   Nemec, Richard ^a   Peterson, Richard ^a   Duntemann, Thomas ^a   Murphy, Margo ^a   Lawson, John M ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH SALICYLATE; CIPROFLOXACIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; OMEPRAZOLE; TETRACYCLINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH MUCOSA;

ADULT; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BIOPSY; BISMUTH; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; EPIDERMAL GROWTH FACTOR; FEMALE; FLOW CYTOMETRY; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SALICYLATES;

EID: 0032862540     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01432.x     Document Type: Article

References (38)

1. Warren J.R., Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1983;1273-1275.
2. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am. 22:1993;89-104.
3. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65-69.
4. Fuchs C.S., Mayer R.J. Gastric carcinoma. N Engl J Med. 333:1995;32-41.
5. Parsonnet J., Hansen S., Rodriguez L., et al. Helicobacter pylori infection and gastric lymphoma. N Eng J Med. 330:1994;1310-1311.
6. Parsonnet J., Friedman G.D., Vandersteen D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 325:1991;1127-1131.
7. Monographs on the evaluation of carcinogenic risks to humans. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 61:1994;177-240.
8. Forman D., Newell D.G., Fullerton F., et al. Association between infection with Helicobacter pylori and the risk of gastric cancer Evidence from a prospective investigation . Br Med J. 302:1991;1302.
9. Nomura A., Stemmermann G.N., Chyou P., et al. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med. 325:1991;1132-1136.
10. Ernst P.B., Crowe S.E., Reyes V.E. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology. 113:1997;S35-S42.
11. Parsonnet J., Friedman G.D., Orentreich N., et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 40:1997;297-301.
12. Konturek P., Ernst H., Konturek J., et al. Salivary and gastric luminal release of epidermal growth factor under basal conditions and after pentagastrin stimulation in healthy subjects and in duodenal ulcer patients before and after eradication of Helicobacter pylori. J Physiol Pharmacol. 47:1996;187-194.
13. Brenes F., Ruiz B., Correa P., et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium Pre- and post-eradication indices of proliferating cell nuclear antigen . Am J Gastroenterol. 88:1993;1870-1875.
14. Jankowski J., Al-Rawi H., Johnston D., et al. Growth regulatory peptides in gastric mucosa. Clin Sci. 82:1992;581-587.
15. Abe S., Sasano H., Katoh K., et al. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa. Dig Dis Sci. 42:1997;1199-1209.
16. Joshi V., Ray G.S., Goldenring J.R. Inhibition of parietal cell acid secretion is mediated by the classical epidermal growth factor receptor. Dig Dis Sci. 42:1997;1194-1198.
17. Konturek P.C., Ernst H., Brzozowski T., et al. Expression of epidermal growth factor and transforming growth factor-α after exposure of rat gastric mucosa to stress. Scand J Gastroenterol. 31:1996;209-216.
18. Tokunga A., Onda M., Okuda T., et al. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer. 75:1995;1418-1425.
19. Barnard J.A., Beauchamp R.D., Russell W.E., et al. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology. 108:1995;564-580.
20. Stoscheck C.M., King L.E. Role of epidermal growth factor in carcinogenesis. Cancer Res. 46:1986;1030-1037.
21. Hamburger A.W., White C.P., Brown R.W. Effect of epidermal growth factor on proliferation of human tumor cells in soft agar. J Natl Cancer Inst. 67:1981;825-830.
22. Singletary S.E., Baker F.L., Spitzer G., et al. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res. 47:1987;403-406.
23. Kajikawa K., Yasui W., Sumiyoshi H., et al. Expression of epidermal growth factor in human tissues Immunohistochemical and biochemical analysis . Virchows Arch. 418:1991;27-32.
24. Pfeiffer A., Rothbauer E., Wiebecke B., et al. Increased epidermal growth factor receptors in gastric carcinomas. Gastroenterology. 98:1990;961-967.
25. Sakai K., Mori S., Kawamoto T., et al. Expression of epidermal growth factor receptor on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst. 77:1986;1047-1052.
26. Messa C., DiLeo A., Greco B., et al. Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis Gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy . Immunopharmacol Immunotoxicol. 18:1996;1-13.
27. Tunio A.M., Holton J., Hobsley M. Gastric juice epidermal growth factor concentration and Helicobacter pylori in patients with duodenal ulcer. Br J Surg. 82:1995;1204-1206.
28. Tunio A.M., Hobsley M. Epidermal growth factor in saliva and gastric juice:response to histamine. Gut. 37:1995;335-339.
29. Konturek P.C., Konturek S.J., Bobrzynski A., et al. Helicobacter and impaired gastric secetory functions associated with duodenal ulcer and atrophic gastritis. J Physiol Pharmacol. 48:1997;365-373.
30. Jankowski J., Hopwood D., Pringle R., et al. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux A putative model for carcinogenesis . Am J Gastroenterol. 88:1993;402-408.
31. Hopwood D., Jankowski J., Milne G., et al. Flow cytometry of oesophageal mucosal biopsies, epidermal growth factor receptor, and CD15. J Pathol. 167:1992;321-326.
32. Jankowski J., Hopwood D., Wormsley K.G. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol. 27:1992;147-154.
33. Jankowski J., Murphy S., Coghill G., et al. Epidermal growth factor in the oesophagus. Gut. 33:1992;1448-1453.
34. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis, the updated Sydney system. Am J Surg Pathol. 20:1996;1161-1181.
35. Konturek P.C., Ernst H., Konturek S.J., et al. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut. 40:1997;463-469.
36. Brotherick I., Lennard T.W., Wilkinson S.E. Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay. Cytometry. 16:1994;262-269.
37. Stacchini A., Fubini L., Aglietta M. Flow cytometric detection and quantitative analysis of the GM-CSF receptor in human granulocytes and comparison with the radioligand binding assay. Cytometry. 24:1996;374-381.
38. Playford R., Wright N., Goodlad R. Concentrations of epidermal growth factor in human saliva and gastric juice. Gut. 38:1996;629-630.